bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
bluebird bio reports 2021 executive compensation
By ExecPay News
Published: May 2, 2022
bluebird bio reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, seven executives at bluebird bio received on average a compensation package of $4.6M, a 26% increase compared to previous year.
Average pay of disclosed executives at bluebird bio
Andrew Obenshain, Chief Executive Officer, received $9.3M in total. 59% of Obenshain's compensation, or $5.4M, was in option awards. Obenshain also received $345K in non-equity incentive plan, $486K in salary, $3M in stock awards, as well as $12K in other compensation.
Nick Leschly, Chief Executive Officer, received a compensation package of $7.3M, which increased by 17% compared to previous year. 66% of the compensation package, or $4.8M, was in stock awards.
Jason F. Cole, Chief Business Officer, earned $3.5M in 2021.
Gina Consylman, Chief Financial Officer, received $3.4M in 2021.
William D. Baird, III, Chief Financial Officer, earned $3.1M in 2021, a 30% increase compared to previous year.
Philip D. Gregory, Chief Scientific Officer, received $3.1M in 2021, which increases by 34% compared to 2020.
Thomas J. Klima, Chief Commercial Officer, earned $2.3M in 2021.
Related executives
Andrew Obenshain
bluebird bio
Chief Executive Officer
Gina Consylman
bluebird bio
Chief Financial Officer
Jason Cole
bluebird bio
Chief Strategy & Financial Officer former
Thomas Klima
bluebird bio
Chief Commercial and Operating Officer
Nick Leschly
bluebird bio
Chief Executive Officer
William Baird
bluebird bio
Chief Financial Officer
Philip Gregory
bluebird bio
Chief Scientific Officer
You may also like
Source: SEC filing on May 2, 2022.